Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?-Reference-Cited by-同舟云学术

Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?

Published:2021-10-29 Issue: Volume: Page:
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hematol

Author:

Kawata Eri¹²³^ORCID,Hedley Benjamin D.⁴,Chin‐Yee Benjamin¹⁵,Xenocostas Anargyros¹⁵,Lazo‐Langner Alejandro¹⁵^ORCID,Hsia Cyrus C.¹⁵⁶,Howson‐Jan Kang¹⁵,Yang Ping⁶⁷,Levy Michael A.⁸⁹,Santos Stephanie⁸,Bhai Pratibha⁸,Howlett Christopher⁶⁸,Lin Hanxin⁶⁸,Kadour Mike⁴⁶⁹,Sadikovic Bekim⁶⁸⁹^ORCID,Chin‐Yee Ian¹⁵⁶^ORCID

Affiliation:

1. Division of Hematology Department of Medicine London Health Sciences Centre London Ontario Canada

2. Department of Hematology Panasonic Health Insurance Organization Matsushita Memorial Hospital Moriguchi Japan

3. Division of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan

4. Department of Pathology and Laboratory Medicine London Health Sciences Centre London Ontario Canada

5. Division of Hematology Department of Medicine Schulich School of Medicine and Dentistry Western University London Ontario Canada

6. Department of Pathology and Laboratory Medicine Schulich School of Medicine and Dentistry Western University London Ontario Canada

7. Cytogenetics Laboratory London Health Sciences Centre London Ontario Canada

8. Molecular Diagnostic Division London Health Sciences Centre London Ontario Canada

9. Verspeeten Clinical Genome Centre London Health Sciences Centre London Ontario Canada

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13747

Reference36 articles.

1. Next-generation sequencing - feasibility and practicality in haematology

2. The value of next‐generation sequencing in the screening and evaluation of hematologic neoplasms in clinical practice;Northrup V;Am J Clin Pathol,2020

3. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R

4. Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies

5. Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome;Kawata E;Br J Haematol,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding Goldilocks: Choosing Wisely Together in Hematology/Oncology;JCO Oncology Practice;2024-01-08

2. Qualità dei metodi di sequenziamento massivo parallelo/sequenziamento di nuova generazione (MPS/NGS);La Rivista Italiana della Medicina di Laboratorio;2023-08

3. Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies;Molecular Diagnosis & Therapy;2022-04-05